Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

Condition:   Small Cell Lung Cancer Limited Stage Intervention:   Drug: Toripalimab Sponsors:   Sun Yat-sen University;   The First Affiliated Hospital of Guangzhou Medical University;   Guangzhou Panyu Central Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials